Princeton Global Asset Management LLC Neurocrine Biosciences Inc Transaction History

Princeton Global Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	BUY	$86.18 - $99.03 $6,463 - $7,427	75 Added 937.5%	83 $8,000
Q3 2021 Nov 03, 2021	SELL	$86.18 - $99.03 $6,463 - $7,427	-75 Reduced 90.36%	8 $8,000
Q3 2019 Dec 03, 2019	SELL	$83.82 - $101.5 $1,173 - $1,421	-14 Reduced 14.43%	83 $8,000
Q2 2019 Sep 06, 2019	BUY	$72.24 - $91.27 $7,007 - $8,853	97 New	97 $8,000

654

96.5M

282K

281K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.4B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Princeton Global Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Princeton Global Asset Management LLC with notifications on news.